centration of the same sample is used to correct for varying rates of urine flow. Thus, random samples of urine may be used for enzyme assay and a result may be obtained within 45 minutes. This has important practical advantages.
Introduction
Fulminant hyperthermia is a complex genetic disease which occurs in various animals and man.' Our observation of raised 
Methods and Materials
Direct calorimetric measurements were made in the Missouri Partitional Calorimeter.2 Pigs susceptible to the fulminant hyperthermiastress syndrome were raised at the Sinclair Experimental Medicine Research Farm. The five animals used were transported from the farm to the calorimeter in individual crates. They were not fed but had had free access to water during the previous 24 hours. Each animal was carefully coaxed out of the crate and into the calorimeter cage with a minimum of excitement and stress. Each animal was placed inside the calorimeter chamber and the recorders were activated. Their weights ranged from 45 to 63 kg.
Results
Three of the five animals (P-5-1, P-5-4, and P-5-5) adjusted quickly to their new environment, proceeding to lie down and go to sleep, and produced stable readings. The other two animals (P-5-2 and P-7-1), however, showed high rates of carbon dixoide production, oxygen consumption, and total heat production as soon as the chamber door was secured. They did not lie down and rest but became agitated and constantly moved about. Within 10-20 minutes they had clearly developed the fulminant hyperthermia-stress syndrome. Neither animal had shown symptoms of excitement or distress before entering the chamber.
The following data were obtained from P-7-1; they typify the events that occurred during the development of the syndrome.
Total heat production started at about 14-2 J (3 4 kcal) h-' kg-' and within 30 minutes was over 25-9 J (6-2 kcal) h-' kg-'. Unfortunately the total heat production exceeded the ranges of the recorders but was over 28-25 J (6-76 kcal) h-' kg-' (fig. 1 ). The heat losses in water vapour from the lungs showed a rapid rate of increase and exceeded 8-36 J (2-0 kcal) h-' kg-' when the recorder went off the scale ( fig. 2 even more important in view of the fact that heat loss by radiation ceases early in the syndrome.
Heat losses by convection are shown in fig. 3 . The animal was producing about 12-54 J (3-0 kcal) h-1 kg-1 when placed in the chamber. Within 10 minutes heat production had risen to 15-46 J (3 7 kcal) h-1 kg-1, and this was maintained for about 20 minutes. The level then rose to 19-64 J (4 7 kcal) h-1 kg-1 for about 10 minutes. At that point the recorder went off the scale. After the animal died there was a gradual decrease in heat losses by convection. The stepwise increase in heat loss indicated that the animal was trying to compensate for the high rate of heat production. One of the most interesting findings concerned heat loss due to radiation ( fig. 4 ). There was a rapid increase in the rate of heat loss by radiation for the first 20 minutes of the syndrome, reaching 2-5 J (0-6 kcal) h-1 kg-1. At that point an additional factor (probably peripheral vasoconstriction) was initiated which rapidly decreased heat losses via the skin to a value below zero. This was maintained for about 10 minutes and coincided with the period of maximum heat Carbon dioxide production (19-65 ml/min-1 kg-1) and oxygen consumption (18-04 ml/min-m kg-') in P-7-1 and P-5-2 was about 10-fold higher than normal when the animals were placed in the chamber. After the syndrome developed the metabolic rate increased to 26-93 ml min-m kg-1 for carbon dioxide production and 26-94 ml/ min-' kg-' for oxygen consumption when the recorders went off the scale. This is more than a 17-fold increase in the metabolic rate of susceptible animals. The respiratory quotient was approximately 10 before and during the syndrome. We also observed an exaggerated response (as reflected by carbon dioxide production and oxygen consumption) to movement by these two pigs.
Discussion
The fulminant hyperthermia-stress syndrome is characterized by hyperthermia, and we have documented the magnitude of the hypermetabolism that occurs in such genetically susceptible animals. The observation that the stress of being placed in the calorimeter is enough to trigger the syndrome in two animals with a rate of metabolism accelerated 10-fold suggests that the nervous system plays a major part in initiating the syndrome. We suggested previously that the release of noradrenaline by the peripheral adrenergic nerve is probably the key triggering event. ' The observation that heat loss by radiation ceases early in the course of the syndrome and that the radiation readout falls to a negative value suggests that an intense peripheral vasoconstriction develops in susceptible animals. We had previously observed peripheral vasoconstriction by another method.3 This intense peripheral vasoconstriction would (1) alter blood flow from skin to core tissues, (2) cause heat retention in core tissues because of a decrease in heat loss by radiation, and (3) cause hypoxia in peripheral tissues; the hypoxia would (4) cause an increased rate of glycolysis with consequent lactate accumulation and (5) increase the rate of noradrenaline release by peripheral adrenergic nerves. A summation of the high temperature, hypoxia, and acidity from lactate could result in cell death in peripheral tissues.
These results also help to rationalize several observations on malignant hyperthermia in man. The peripheral vasoconstriction would prevent surface cooling even if the patient were packed in an ice batb. Our results show that the animal was absorbing heat from the environment rather than giving off heat via the skin. This suggested that peripheral vasodilators may be therapeutically effective. We have some results showing that buphenine causes peripheral vasodilatation and thereby allows for heat dissipation via the skin. Surface cooling is then effective. Buphenine, however, does not affect the basic thermogenic mechanism.' Accelerated metabolism and heat retention are the most important factors in causing the high body temperatures observed. The calorimeter does not provide any data on the 413 biochemical mechanism which generates the heat. We, however, favour the "substrate cycling" or "futile cycling" mechanism, which we previously noted in the muscle tissue of susceptible pigs.5 6 Increased rates of substrate cycling may be induced by the excess of noradrenaline activity which we have suggested occurs in these animals.' The substrate cycling mechanism provides a biologically feasible scheme for depleting muscle glycogen, producing lactate and heat which would denature the muscle proteins and produce pale, soft, exudative muscle in the carcasses of susceptible animals.' Introduction Radiotherapy is the treatment of choice of localized Hodgkin's disease. When the disease is widespread, however, treatment with a combination of drugs offers a greatly improved opportunity for long-term control than that obtained with single cytotoxic agents. The most effective drug combination available is still mustine, vincristine (Oncovin), procarbazine, and prednisone (MOPP), which was introduced in 1970. Consideration of these facts suggested that corticosteroids contributed little to the efficacy of the MOPP regimen while increasing the possiblity of complications. A prospective controlled trial was therefore inaugurated comparingMOPP and MOP. We expected that there would be a similar complete remission rate with both combinations but that some sparing of the bone marrow might be seen in the group treated by MOPP.
All patients with stage IV Hodgkin's disease presenting within the trial period were randomized into two treatment groups. The drugs were given as follows: on both regimens mustine 6 mg/M2 and vincristine 14 mg/in2 were given on days 1 and 8 and procarbazine on days 1 to 10. On the MOPP regimen prednisone 25 mg/M2 was also given on days 1 to 14.
Results
The results of treatment were evaluated in 90 patients all of whom were followed up for at least six months after the original biopsy; 49 received treatment with MOPP and 41 with MOP. Treatment with MOPP led to complete remission in 39 cases (80%), partial remission (more than 50%/') in eight (16%), and no remission in two (4%).
Treatment with MOP led to complete remission in 18 (44%), partial remission in 17 (42%), and no remission in six (15% table i). Statistical evaluation of these results showed that there were no significant differences in the survival rates but that there was a highly significant difference in the complete remission rates (P<0005; X2= 10-8).
